There are 10 resources available
Welcome and Introduction
Presenter: S. Bujassoum, QT; N. Harbeck, DE
Session: Welcome and introduction
Resources:
Slides
Epidemiology of Breast Cancer in the Gulf Region
Presenter: S. Bujassoum, QT
Session: Session 1 – Epidemiology of Breast Cancer in the Gulf Region
Resources:
Slides
Early breast cancer
Presenter: N. Harbeck, DE
Session: Session 2 – CDK4/6 inhibitors in EBC and MBC
Resources:
Slides
Metastatic breast cancer
Presenter: R. Bartsch, AT
Session: Session 2 – CDK4/6 inhibitors in EBC and MBC
Resources:
Slides
Clinically relevant biomarkers (PI3KCA, ESR1, AKT pathway, liquid biopsy, NGS, gBRCA)
Presenter: F. Penault-lLlorca, FR
Session: Session 3 – What to do after CDK4/6 inhibition in advanced breast cancer
Resources:
Slides
Oral SERDs
Presenter: R. Bartsch, AT
Session: Session 3 – What to do after CDK4/6 inhibition in advanced breast cancer
Resources:
Slides
Management of endocrine sensitive disease
Presenter: A. Gennari, IT
Session: Session 4 – Treatment strategies
Resources:
Slides
Management of endocrine resistant disease
Presenter: N. Harbeck, IT
Session: Session 4 – Treatment strategies
Resources:
Slides
The potential future for oral SERDs “ongoing clinical trials for oral SERDs” in early & metastatic setting
Presenter: R. Bartsch, AT
Session: Session 4 – Treatment strategies
Resources:
Slides
Management of adverse events of new endocrine-based therapies in metastatic breast cancer: Balancing efficacy and toxicity
Presenter: A. Gennari, IT
Session: Clinical Practice Session – Side effects management
Resources:
Slides